Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

In what clinical scenario, if any, would you consider APBI appropriate treatment for a patient with triple-negative breast cancer?

5
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Currently, none of the prospective studies did APBI after neoadjuvant chemotherapy so that subset, we don't offer APBI (need studies in this space).As far as denovo early-stage TNBC, we have not been doing APBI as were only part of one (B39) of all prospective randomized studies with PBI and also sh...

Would you hold CGRP (calcitonin gene-related peptide) monoclonal antibodies such as Eptinezumab-jjmr (Vyepti) before, during, or after lung SBRT?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Case Western Reserve University

No, I will not hold CGRP monoclonal antibodies during lung SBRT as at present, there is no data suggesting the detrimental effect of doing so. Moreover, the drug is conveniently given q 3months while SBRT is usually completed within 2 weeks. Therefore, most lung SBRT can be scheduled outside of the ...

What is the best fractionation for head and neck patients who cannot receive systemic therapy due to KPS or medical comorbidities?

4
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Michigan

In my experience, using the DAHANCA regimen (once daily 4 days a week, twice daily once a week), but treating only PTV1 in the second daily fraction, is quite well tolerated. The original DAHANCA treated all targets twice daily. However, using IMRT it is possible to avoid prophylactically irradiated...

When would you use PSMA PET over conventional imaging for prostate cancer?

2
2 Answers

Mednet Member
Mednet Member
Medical Oncology · University of Michigan

So far, most (but not all) prospective data for molecular imaging has been obtained in the setting of biochemical recurrence and that is where I have used it most outside of trials.In the primary disease setting, some trials examined the utility to detect nodal and distant disease (like OSPREY publi...

How would you manage a patient with a subcentimeter stage I vaginal squamous cell carcinoma after a positive deep margin post local excision?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I would get MRI with vaginal gel done along with PET/CT (assuming negative) If there is no LVSI on pathology, disease is not high grade and based on MRI, I would cover vaginal wall apical residual thickness with intracavitary brachytherapy then I would treat with 7Gy x5 prescribed to volume and lim...

Can pre-op chemoRT be used to potentially downstage an early stage rectal cancer (i.e. T2 N0) for a sphincter sparing operation?

4
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · Fox Chase Cancer Center

It is certainly appropriate to consider pre-operative chemoRT in an early stage rectal cancer that would not otherwise require neoadjuvant chemoradiation.The goal here would be to convert the operation from one resulting in a permanent ostomy (APR) to one allowing sphincter sparing (LAR). Good data ...

What is your typical target/field when treating a patient with 5 Gy x 5 fractions pre-operatively for rectal cancer?

4
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Washington University School of Medicine

The European experience with short course preoperative radiotherapy uses treatment portals that are somewhat smaller than what many of us utilize in the US. At Washington University we have a long experience (that pre-dates the Swedish trials) with 4Gy X 5fx for readily resectable tumors. The cases ...

Would you offer additional radiation therapy in a medically inoperable patient with rectal adenocarcinoma who has a persistently palpable tumor after definitive chemoradiation therapy?

1
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Northeast Alabama Regional Medical Center

I recently was writing up some data about pCR after SBRT for lung and it still seems a bit of a surprise to folks that pCR rates increase over time after XRT. The velocity of this change over time is almost certainly related to histology and other factors like tumor doubling time. It's all about the...

Is there a role for unilateral hippocampal sparing?

5
5 Answers

Mednet Member
Mednet Member
Radiation Oncology · Mercy Clinic Radiation Oncology

There is some lateralization of hippocampus function which may impact decision making.The left hippocampus seems to play more of a role in episodic verbal memory, while the right plays more of a role in spatial processing. Our neurosurgeon has told me before that a left hippocampectomy is much worse...

Do you give post-operative radiation to Ewing sarcoma if there is poor histologic response to neoadjuvant therapy in a completely resected tumor?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · St Jude Children's Research Hospital

US Ewing studies conducted through COG have used histologic response in more recent protocols to play a key role in how margins are assessed, such that patients with >90% necrosis and inflammatory or coagulative necrosis at the margin require RT, while those with bland scar or fibrous tissue do not....